Microglia: a cellular vehicle for CNS gene therapy
Open Access
- 1 November 2006
- journal article
- editorial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 116 (11) , 2857-2860
- https://doi.org/10.1172/jci30230
Abstract
Metachromatic leukodystrophy (MLD) is a lysosomal storage disease caused by deficiency of the enzyme arylsulfatase A (ARSA). MLD is characterized by progressive demyelination and neurological deficits. Treatment of MLD is still a challenge due to the fact that the blood-brain barrier is a major obstacle for most therapeutic substances. In this issue of the JCI, Biffi et al. report that genetically modified hematopoietic precursor cells transduced to overexpress ARSA and transplanted into mice with a targeted disruption of the murine Arsa gene (Arsa–/– mice) migrated into the CNS and cross-corrected brain ARSA deficiency (see the related article beginning on page 3070). Microglia served as a cellular vehicle to effectively deliver the enzyme to other brain cells while hepatocytes overexpressing ARSA increased plasma ARSA levels but failed to deliver ARSA into the CNS.Keywords
This publication has 16 references indexed in Scilit:
- Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in miceJournal of Clinical Investigation, 2006
- See no evil, hear no evil, do no evil: the lessons of immune privilegeNature Immunology, 2006
- Resting Microglial Cells Are Highly Dynamic Surveillants of Brain Parenchyma in VivoScience, 2005
- The blood-brain barrier: Bottleneck in brain drug developmentNeuroRX, 2005
- Gene therapy of metachromatic leukodystrophyExpert Opinion on Biological Therapy, 2005
- Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microgliaThe FASEB Journal, 2004
- LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1Science, 2003
- Developmental plasticity of CNS microgliaProceedings of the National Academy of Sciences, 2001
- Long-term expression and transfer of arylsulfatase A into brain of arylsulfatase A-deficient mice transplanted with bone marrow expressing the arylsulfatase A cDNA from a retroviral vectorGene Therapy, 2000
- Perivascular Microglial Cells of the CNS Are Bone Marrow-Derived and Present Antigen in VivoScience, 1988